MERCK SHARP & DOHME CORP.;ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI, S.R.L.
发明人:
CARROLL, STEVEN S.,MCCAULEY, JOHN A.,OLSEN, DAVID B.,SUMMA, VINCENZO,ROWLEY, MICHAEL,STAHLHUT, MARK W.,HAZUDA, DARIA
申请号：
CA2854129
公开号：
CA2854129A1
申请日:
2012.10.26
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The present invention is directed to compositions comprising inhibitors of hepatitis C virus (HCV) protease and one or more additional therapeutically effective agents. Uses of such compositions as HCV inhibitors and methods of treating infection by HCV by administration of such compositions are also disclosed.
